Table 2.
Demographic and clinical characteristics of the study subjects according to sex-specific type of plaques
| Variables | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|
| NP (n = 39) | CP (n = 74) | NCP/MP (n = 92) | P | NP (n = 40) | CP (n = 46) | NCP/MP (n = 38) | P | |
| Age (years) | 48.5 ± 8.8 | 58.8 ± 9.8 | 57.5 ± 9.6 | < 0.001 | 51.6 ± 9.3 | 65.5 ± 7.2 | 59.9 ± 9.7 | < 0.001 |
| BMI (kg/m2) | 26.4 ± 3.0 | 25.7 ± 3.6 | 26.4 ± 4.1 | 0.470 | 23.7 ± 3.2 | 25.3 ± 3.6 | 24.5 ± 3.0 | 0.100 |
| Hypertension, n (%) | 18 (46.2%) | 49 (66.2%) | 60 (65.2%) | 0.077 | 10 (25.0%) | 32 (69.6%) | 24 (63.2%) | < 0.001 |
| Diabetes, n (%) | 7 (17.9%) | 20 (27.0%) | 29 (31.5%) | 0.280 | 5 (12.5%) | 9 (19.6%) | 12 (31.6%) | 0.113 |
| Dyslipidemia, n (%) | 22 (56.4%) | 61 (82.4%) | 81 (88.0%) | < 0.001 | 17 (42.5%) | 33 (71.7%) | 33 (86.8%) | < 0.001 |
| Smoking, n (%) | 15 (38.5%) | 29 (39.2%) | 40 (43.5%) | 0.803 | 1 (2.5%) | 2 (4.3%) | 3 (7.9%) | 0.530 |
| Alcohol consumption, n (%) | 22 (56.4%) | 36 (48.6%) | 41 (44.6%) | 0.462 | 2 (5.0%) | 2 (4.3%) | 1 (2.6%) | 0.860 |
| History of CAD, n (%) | 6 (15.4%) | 9 (12.2%) | 11 (12.0%) | 0.853 | 6 (15.0%) | 6 (13.0%) | 6 (15.8%) | 0.934 |
| Biochemical parameters | ||||||||
| TC (mmol/L) | 5.03 ± 0.87 | 4.36 ± 1.03 | 4.35 ± 1.22 | 0.003 | 4.87 ± 0.96 | 5.00 ± 1.90 | 5.11 ± 1.32 | 0.765 |
| TG (mmol/L) | 1.83 (1.34, 2.43) | 1.56 (1.09, 2.18) | 1.53 (1.16, 2.14) | 0.226 | 1.43 (0.90, 1.86) | 1.49 (0.97, 2.18) | 1.87 (1.20, 2.56) | 0.079 |
| HDL-C (mmol/L) | 1.11 ± 0.29 | 1.13 ± 0.29 | 1.06 ± 0.27 | 0.328 | 1.28 ± 0.40 | 1.33 ± 0.34 | 1.20 ± 0.27 | 0.185 |
| LDL-C (mmol/L) | 3.14 ± 0.83 | 2.58 ± 0.87 | 2.65 ± 0.97 | 0.006 | 3.01 ± 0.72 | 2.86 ± 0.87 | 3.10 ± 1.00 | 0.441 |
| hsCRP (mg/L) | 1.45 (0.94, 1.92) | 1.24 (0.60, 2.97) | 1.44 (0.80, 2.90) | 0.649 | 0.98 (0.43, 2.36) | 1.50 (0.85, 2.40) | 1.83 (0.89, 4.37) | 0.029 |
| FIB (g/L) | 3.00 ± 0.61 | 2.96 ± 0.52 | 3.16 ± 0.80 | 0.161 | 3.18 ± 0.75 | 3.23 ± 0.51 | 3.68 ± 0.61 | 0.001 |
| Medications, n (%) | ||||||||
| Statins | 15 (38.5%) | 53 (71.6%) | 74 (80.4%) | < 0.001 | 15 (37.5%) | 30 (65.2%) | 26 (68.4%) | 0.009 |
| Aspirin | 21 (53.8%) | 57 (77.0%) | 79 (85.9%) | < 0.001 | 16 (40.0%) | 38 (82.6%) | 28 (73.7%) | < 0.001 |
| Calcium antagonists | 9 (23.1%) | 32 (43.2%) | 28 (30.4%) | 0.066 | 4 (10.0%) | 24 (52.2%) | 11 (28.9%) | < 0.001 |
| ARB/ACEI | 13 (33.3%) | 31 (41.9%) | 49 (53.3%) | 0.084 | 4 (10.0%) | 18 (39.1%) | 12 (31.6%) | 0.008 |
| Beta-blockers | 11 (28.2%) | 42 (56.8%) | 49 (53.3%) | 0.010 | 13 (32.5%) | 20 (43.5%) | 21 (55.3%) | 0.128 |
| Diuretics | 2 (5.1%) | 21 (28.4%) | 22 (23.9%) | 0.015 | 4 (10.0%) | 7 (15.2%) | 6 (15.8%) | 0.707 |